hepatotoxicity

Hepatotoxicity is drug-induced damage to the liver. The liver is the body's main chemical-processing plant, so it sits in the line of fire for almost everything we swallow — which is exactly why it is one of the organs most often injured by medicines.

There are two broad mechanisms. Intrinsic (dose-dependent and predictable) hepatotoxicity occurs when a drug or its metabolite directly poisons liver cells once a threshold is crossed — paracetamol overdose is the classic case, where a reactive metabolite overwhelms protective glutathione. Idiosyncratic hepatotoxicity is rare, unpredictable, often immune-mediated, and not tied to dose — it can appear weeks into treatment in a small minority of users, as with some antibiotics and antiepileptics.

Because the liver both activates and detoxifies many drugs through cytochrome P450 enzymes, it is frequently exposed to reactive intermediates. Damage shows up as raised liver enzymes (transaminases) in the blood, jaundice, or, at worst, acute liver failure. Patterns are described as hepatocellular (cell injury), cholestatic (impaired bile flow), or mixed.

An honest caveat: mild, transient enzyme rises are common and often harmless, while the same drug can rarely cause catastrophic failure. Distinguishing benign 'adaptation' from dangerous injury is one of the harder judgements in drug safety, and is why some drugs require periodic liver monitoring.